More specifically, GAS5 has the potential to inhibit EZH2 transcription by directly interacting with E2F transcription factor 4 (E2F4) and recruiting E2F4 to the promoter of EZH2 in bladder cancer cells [35]. Here, E2F4 is linked to urinary bladder carcinoma.